
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Some Possible Solutions

TRAIN Newsletter—December 2021

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
